Подкорытова О. Л., Томилина Н. А., Бибков Б. Т., Вторенко В. И., Ширинский В. Г., Локтев В. В., Федорова Н. Д., Чура И. С., Родников С. Е.

ЛИТЕРАТУРА
1. Mergener R., Baillie J. Acute pancreatitis. Br. Med. J. 1998; 316: 44—48.
2. Bassi C., Falconi M., Valerio A. Identification of pancreatic infection. In Buchler M (ed) Acute Pancreatitis: Novel Concepts in Biology and Therapy. Blackwell Science, Boston; 1999; 277—282.
3. D’Egidio A. et al. Surgical strategies in treatment of pancreatic necrosis and infection, Br. J. Surg. 2002; 78: 133—137.
4. Guice R. S., Oldham K. T., Johnson K. J. et al. Pancreatitis-induced acute lung injury. An ARDS model. Ann. Surg. 1988; 208: 71—77.
5. Schmid S. W. et al. The role of infection in acute pancreatitis. Gut 1999; 45: 311—316.
6. Cole L., Bellomo R., Journois D., et al. A phase II randomized, controlled trial of continuous hemofiltraition in sepsis. Crit. Care Med. 2002; 30: 100—106.
7. Norman J. The role of cytokines in the pathogenesis of acute pancreatitis. Am. J. Surg. 1998; 175: 76—83.
8. Blinzler L., Sieberth H. G., Stummvoll H. K. Conservative treatment of server necrotizing pancreatitis using early continuous veno-venous HF. Contrib. Nephrol. 1991; 93: 234—236.
9. Bellomo R., Ronco C., Kellum J. A., Mehta R. L., Palevsky P. ARF: definition, outcome measures, animal models, fluid therapy and information technology needs. The Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit. Care 2004; R204—12.
10. Gehbart C. et al. Changes in therapy of server acute pancreatitis. Chrurg. 1994; 65: 33—40.
11. Schmidt J., Werner J. Acute pancreatitis: reliable and prospective conservative therapy. Langenbecks Arch. Chir. Suppl. Congressed 1998; 115: 434—438.
12. Yang Z. et al. Effect of early hemofiltration on pro- and anti-inflammatory responses and multiple organ failure in severe acute pancreatitis. J. Huazhong Univ. Sci. Technolog Med. Sci. 2004; 24 (5): 456—9.
13. Yang Z. et al. Protective effect CVVH and organ damage in patients with severe acute pancreatitis. World J. Gastroenterology 2004; Apr 16 (4): 232—4.
14. Wang H. et al. Clinical effects continuous high volume hemofiltration on acute pancreatitis complicated with multiple organ dysfunction syndrome. World J. Gastroenterology, Sep. 2003; 9 (9): 2096—9.
15. Wang H. et al. Amelioration of hemodynamics and oxygen metabolism by continuous venovenous hemofiltration in experimental porcine pancreatitis. World J. Gastroenterol. 2005 Jan 7; 11 (1): 127—31.
16. En-Qiang Mao et al. Effect of time interval for hemofiltration on the prognosis of severe acute pancreatitis. World J. Gastroenterol. Feb. 2003; 15; 9 (2): 373—376.
17. Hao Wang, Wei-Qin Li, Wei Zhou, Ning Li, Jie-Shou Li. Clinical effects of continuous high volume hemofiltration on severe acute pancreatitis complicated with multiple organ dysfunction syndrome. World J. Gastroenterology 2003; Sept. 9 (9): 2096—2099.
18. Le Gall J. R. et al. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. J. A. M. A. 1993; 270: 2957—2963.
19. Beck D. H. et al.: External validation of the SAPS II, APACHE II, APACHE III prognostic models in South England: a multicenter study. Intensive Care Med. 2003; 29: 249—256.
20. Abosaif N. Y. et al.: The outcome of ARF in the intensive care unit according to RIFLE: model applicability, sensitivity, and predictability. Am. J. Kidney Dis. 2005; 46: 1038—1048.
21. Ronco C., Bellomo R., Homel P., et al.: Effects of different doses in CVVH on outcomes of ARF: Aprospective randomized trial. Lancet 2000; 355: 26—30.